alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Editorial Note on Part 225
Editorial Note: Nomenclature changes to part 225 appear at 69 FR 77618, Dec. 28, 2004.

§ 225.11 Transactions requiring Board approval. The following transactions require the Board's prior approval under section 3 of the Bank Holding Company Act except as exempted under § 225.12 or as otherwise covered by § 225.17 of this subpart: ( a ) *Formation of bank holding company.* Any action that causes a bank or other company to become a bank holding company.
( b ) *Acquisition of subsidiary bank.* Any action that causes a bank to become a subsidiary of a bank holding company.
( c ) *Acquisition of control of bank or bank holding company securities.* ( 1 ) The acquisition by a bank holding company of direct or indirect ownership or control of any voting securities of a bank or bank holding company, if the acquisition results in the company's control of more than 5 percent of the outstanding shares of any class of voting securities of the bank or bank holding company.
( 2 ) An acquisition includes the purchase of additional securities through the exercise of preemptive rights, but does not include securities received in a stock dividend or stock split that does not alter the bank holding company's proportional share of any class of voting securities.
( d ) *Acquisition of bank assets.* The acquisition by a bank holding company or by a subsidiary thereof (other than a bank) of all or substantially all of the assets of a bank.
( e ) *Merger of bank holding companies.* The merger or consolidation of bank holding companies, including a merger through the purchase of assets and assumption of liabilities.
( f ) *Transactions by foreign banking organization.* Any transaction described in paragraphs (a) through (e) of this section by a foreign banking organization that involves the acquisition of an interest in a U.S. bank or in a bank holding company for which application would be required if the foreign banking organization were a bank holding company.
26928.0710.8712010401

Medication Treatment, 

Evaluation, and 

Management (MedTEAM)

CONTACT INFO HERE

Evidence-based treatment works

A systematic, evidence-based approach 

for offering medication treatment to 

people with serious mental illnesses

This document was produced for the Substance Abuse and Mental Health Services 

Administration (SAMHSA), U.S. Department of Health and Human Services (HHS) 

under purchase order number HHSP233200600826P with the University of Texas 

at San Antonio and contract number 270-03-6005 with Westat.

Printed 2010 HHS Publication No. SMA-10-4548

U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration

Center for Mental Health Services

www.samhsa.gov

U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration

Center for Mental Health Services

www.samhsa.gov
What is

Medication Treatment, 

Evaluation, and Management?

Medication Treatment, Evaluation, 

and Management (MedTEAM), an 

evidence-based approach, helps 

medication prescribers integrate 

the best current research evidence, 

clinical expertise, and consumer 

experience. Medication treatment 

is based on active consumer 

participation, mutual communication, 

and shared decisionmaking.

Why participate in 

MedTEAM?

People with serious mental illnesses often have 

long and complex medication histories. MedTEAM 

offers a systematic approach to documenting which 

medications consumers have tried and their effects. 

Coupled with the latest research, this information 

helps consumers and their treatment teams make 

the best medication decisions to support their 

recovery goals.

How does MedTEAM work?

■ Informed 

medication 

decisions

Mental health systems and agencies develop 

a systematic plan to ensure that the latest 

scientific evidence guides medication 

decisions.

■ Team approach Consumers and prescribers work 

together with a team of practitioners to 

systematically gather the information 

needed for effective medication 

management.

■ Medicationrelated 

outcomes

Routinely using medication-related outcome 

measures helps prescribers and consumers 

evaluate whether medications are having 

the desired effect.

■ High-quality 

documentation

High-quality documentation provides a 

record of medication response over the 

consumer’s lifetime.

■ Shared 

decisionmaking

Consumers are given information 

about their medications, share in the 

decisionmaking process, and are involved in 

evaluating their progress.

Informed clinical judgment and shared decisionmaking are at the core of effective prescribing
9278370



### SIXTH SUPPLEMENT TO FINAL APPLICATION UNDER 49 U.S.C.§ 47134 FOR PRIVATIZATION OF CHICAGO MIDWAY INTERNATIONAL AIRPORT The City of Chicago (the “City”) hereby supplements the Final Application, filed October 14, 2008, along with the first Supplement submitted on October 15, 2008, the second Supplement submitted on March 5, 2009, the third Supplement submitted on January 29, 2010, the fourth Supplement submitted on April 30, 2010 and the fifth Supplement submitted on July 30, 2010. The City has continued to review with its advisors, the airlines operating at Midway Airport and others all of the factors affecting the prospective timing and terms of completion of the Midway Airport privatization. On September 7, 2010, Mayor Richard M. Daley announced his intention not to be a candidate for re-election in February 2011. Mayor Daley subsequently reiterated his strong support for the Midway Airport privatization and his belief that it can be completed on terms favorable to the City. He also stated his view that it was better to leave such completion to his successor, rather than to seek to do it before he leaves office next May. The newly-elected Chicago City Council also takes office in May 2011. The City expects that the new Mayor and Council will review the Midway Airport privatization upon taking office and expects to report on its proposed course of action with respect to completion of the privatization on or before July 31, 2011.

The date of this Supplement is November 30, 2010.
§ 226.30 Limitation on rates. A creditor shall include in any consumer credit contract secured by a dwelling and subject to the act and this regulation the maximum interest rate that may be imposed during the term of the obligation[50] when: ( a ) In the case of closed-end credit, the annual percentage rate may increase after consummation, or
( b ) In the case of open-end credit, the annual percentage rate may increase during the plan.
[75 FR 7818, Feb. 22, 2010] Footnotes -
226.30
[50] [Reserved]
§ 1278.5 Approval by Director. ( a ) *Standards.* In determining whether to approve a merger of Banks under the authority of § 1278.2, the Director shall take into consideration the financial and managerial resources of the Constituent Banks, the future prospects of the Continuing Bank, and the effect of the proposed merger on the safety and soundness of the Continuing Bank and the Bank system.
( b ) *Determination by Director.* After FHFA determines that a merger application is complete, as provided in § 1278.4(c), the Director shall, within 30 days, either approve or deny the merger application. An approval of a merger application may include any conditions the Director determines to be appropriate, and shall in all cases be conditioned on each Constituent Bank demonstrating that it has obtained its members' ratification of the merger agreement in accordance with the requirements of § 1278.6 by submitting to FHFA: ( 1 ) A certified copy of the members' resolution ratifying the merger agreement, on which the members cast their votes; and
( 2 ) A certification of the member vote from the Bank's corporate secretary or from an independent third party.
( c ) *Notice.* If the Director approves the merger application, FHFA shall provide written notice of the approval and any conditions to each Constituent Bank, as well as to each other Bank and the Office of Finance. If the Director denies the merger application, FHFA shall provide written notice of the denial to each Constituent Bank, as well as to each other Bank and the Office of Finance, and the notice to the Constituent Banks shall include a statement of the reasons for the denial.
Exhibit 24.4
                                POWER OF ATTORNEY

         KNOW ALL MEN BY THESE PRESENTS that I, Walker Lewis, in my individual
capacity and as Director of Unilab Corporation, a Delaware corporation (the
"Company"), hereby constitute and appoint Mark L. Bibi, Richard A. Michaelson
and/or Brian D. Urban, severally or any one of them acting alone, from the date
hereof until such time as this Power of Attorney is revoked in writing, to act
as my true and lawful agent and attorney-in-fact, in my name and on my behalf to
execute, consent to, swear to, acknowledge, record, file, amend and/or modify
and deliver one or more registration statements for the filing of securities of
the Company under the Securities Act of 1933, as amended (the "Securities Act")
and any and all subsequent filings made by or on behalf of the Company with the
United States Securities and Exchange Commission pursuant to the Securities Act
and/or the Securities Exchange Act of 1934, as amended.

         IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney
this 13th day of October 1994.

                                                 -------------------------------
                                                 Walker Lewis
121 STAT. 224 PUBLIC LAW 110–34—JUNE 14, 2007

LEGISLATIVE HISTORY—S. 214 (H.R. 580):

HOUSE REPORTS: No. 110–58 accompanying H.R. 580 (Comm. on the Judiciary).

CONGRESSIONAL RECORD, Vol. 153 (2007):

Mar. 19, 20, considered and passed Senate.

May 22, considered and passed House.

Æ

Public Law 110–34

110th Congress

An Act

To amend chapter 35 of title 28, United States Code, to preserve the independence

of United States attorneys.

Be it enacted by the Senate and House of Representatives of

the United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

This Act may be cited as the ‘‘Preserving United States Attorney

Independence Act of 2007’’.

SEC. 2. VACANCIES.

Section 546 of title 28, United States Code, is amended by

striking subsection (c) and inserting the following:

‘‘(c) A person appointed as United States attorney under this

section may serve until the earlier of—

‘‘(1) the qualification of a United States attorney for such

district appointed by the President under section 541 of this

title; or

‘‘(2) the expiration of 120 days after appointment by the

Attorney General under this section.

‘‘(d) If an appointment expires under subsection (c)(2), the district court for such district may appoint a United States attorney

to serve until the vacancy is filled. The order of appointment by

the court shall be filed with the clerk of the court.’’.

SEC. 3. APPLICABILITY.

(a) IN GENERAL.—The amendments made by this Act shall

take effect on the date of enactment of this Act.

(b) APPLICATION.—

(1) IN GENERAL.—Any person serving as a United States

attorney on the day before the date of enactment of this Act

who was appointed under section 546 of title 28, United States

Code, may serve until the earlier of—

(A) the qualification of a United States attorney for

such district appointed by the President under section 541

of that title; or

(B) 120 days after the date of enactment of this Act.

(2) EXPIRED APPOINTMENTS.—If an appointment expires

under paragraph (1), the district court for that district may

appoint a United States attorney for that district under section

546(d) of title 28, United States Code, as added by this Act.

Approved June 14, 2007.

28 USC 546 note.

Preserving

United States

Attorney

Independence Act

of 2007.

28 USC 1 note.

June 14, 2007

[S. 214]
<TABLE>
<CAPTION>

                                                                                                  Exhibit 11.1

                                      Bell & Howell Company and Subsidiaries
                                 Computation of Earnings (Loss) Per Common Share
                                       Fiscal Years 1994, 1995 and 1996

                            (Dollars and shares in thousands, except per share data)






                                                                     1994          1995          1996
                                                                   --------      --------      --------
<S>                                                               <C>            <C>           <C>
Net earnings (loss):

Earnings (loss) before extraordinary items ....................   $ (9,016)      $ 19,210      $ 25,655

Extraordinary losses ..........................................       (978)        (3,219)       (2,585)
                                                                   -------        -------       -------
Net earnings (loss) ...........................................     (9,994)        15,991        23,070
                                                                   =======        =======       =======

Average number of common shares and
equivalents outstanding:

  Primary .....................................................     13,267         16,585        18,560

  Fully diluted ...............................................     13,267         16,585        18,560

Net earnings per common share:

  Primary:

  Earnings (loss) before extraordinary items ...................   $  (.68)      $   1.15      $   1.38

  Extraordinary losses ........................................       (.07)          (.19)         (.14)
                                                                   -------        -------       -------
  Net earnings (loss) per common share ........................   $   (.75)      $    .96      $   1.24
                                                                   =======        =======       =======

  Fully diluted:

  Earnings (loss) before extraordinary items ..................   $   (.68)      $   1.15      $   1.38

  Extraordinary losses ........................................       (.07)          (.19)         (.14)
                                                                   -------        -------       -------
  Net earnings (loss) per common share ........................   $   (.75)      $    .96      $   1.24
                                                                   =======        =======       =======

</TABLE>
§ 150.560 When may the OCC revoke my fiduciary powers? The OCC may revoke your fiduciary powers if it determines that you have done any of the following: ( a ) Exercised those fiduciary powers unlawfully or unsoundly.
( b ) Failed to exercise those fiduciary powers for five consecutive years.
( c ) Otherwise failed to follow the requirements of this part.
<TABLE> <S> <C>

<ARTICLE> 5
<CIK>  0000793981 
<NAME> WEALTH INTERNATIONAL, INC.
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          FEB-28-1996
<PERIOD-END>                               NOV-30-1996
<CASH>                                          54,769
<SECURITIES>                                         0
<RECEIVABLES>                                    8,910
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                77,070
<PP&E>                                          65,214 
<DEPRECIATION>                                  (7,334)
<TOTAL-ASSETS>                                 134,950
<CURRENT-LIABILITIES>                          514,272
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        11,511
<OTHER-SE>                                    (390,833)   
<TOTAL-LIABILITY-AND-EQUITY>                   134,950
<SALES>                                        615,314
<TOTAL-REVENUES>                               615,949
<CGS>                                          185,084
<TOTAL-COSTS>                                  685,701
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                (69,752)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (69,752)
<EPS-PRIMARY>                                   (0.006)
<EPS-DILUTED>                                   (0.006)
# C_2007301EN.01001901.xml

| 13.12.2007 | EN | Official Journal of the European Union | C 301/19 |
| --- | --- | --- | --- |

13.12.2007

EN

Official Journal of the European Union

C 301/19

---

Request for an Advisory Opinion from the EFTA Court by Hæstiréttur Íslands dated 8 May 2007 in the case of HOB vín ehf v Faxaflóahafnir sf.

(Case E-6/07)

(2007/C 301/11)

A request has been made to the EFTA Court by a letter of 8 May 2007 from Hæstiréttur Íslands (the Supreme Court of Iceland), which was received at the Court Registry on 21 May 2007, for an Advisory Opinion in the case of HOB vín ehf v Faxaflóahafnir sf., on the following questions:

| 1. | Does the levying of charges by a partnership owned by several municipalities, in connection with the import of alcoholic beverages from other EEA States through a port owned by the partnership, fall under the provisions of Articles 10, 11 or 14 of the EEA Agreement? The question is based on the premise that the operation of the port is not regarded in law as a public operation; the levying of the charges is based on an authorisation in law and the charges are to meet the cost of the services provided, together with a share of the joint operation of the port. |
| --- | --- |

1.

Does the levying of charges by a partnership owned by several municipalities, in connection with the import of alcoholic beverages from other EEA States through a port owned by the partnership, fall under the provisions of Articles 10, 11 or 14 of the EEA Agreement? The question is based on the premise that the operation of the port is not regarded in law as a public operation; the levying of the charges is based on an authorisation in law and the charges are to meet the cost of the services provided, together with a share of the joint operation of the port.

| 2. | If the answer to the first question is such that any of the abovementioned provisions of the EEA Agreement apply, does that provision preclude the levying of charges of the type referred to in the first question? The question is based on the premise that higher charges are imposed in connection with the import of alcoholic beverages than of non-alcoholic beverages, and that in Iceland alcoholic beverages are generally imported, inter alia from other EEA States. |
| --- | --- |

2.

If the answer to the first question is such that any of the abovementioned provisions of the EEA Agreement apply, does that provision preclude the levying of charges of the type referred to in the first question? The question is based on the premise that higher charges are imposed in connection with the import of alcoholic beverages than of non-alcoholic beverages, and that in Iceland alcoholic beverages are generally imported, inter alia from other EEA States.

inter alia

---
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Agriculture

# AGENCY:

Forest Service, USDA Forest Service 

# ACTION:

Action of meeting.

# SUMMARY:

The Hood/Willamette Resource Advisory Committee (RAC) will meet on Wednesday, October 28, 2009. The meeting and field trip is scheduled to begin at 9:30 a.m. and will conclude at approximately 4:30 p.m. The meeting will be held at the Mt. Hood National Forest Headquarters; 16400 Champion Way; Sandy, Oregon; (503) 668-1700. The tentative agenda includes: (1) Public Forum; and (2) Field Trip to Title II Projects.

The Public Forum is tentatively scheduled to begin at 9:45 a.m. Time allotted for individual presentations will be limited to 3-4 minutes. Written comments are encouraged, particularly if the material cannot be presented within the time limits for the Public Forum. Written comments may be submitted prior to the October 28th meeting by sending them to Designated Federal Official Connie Athman at the address given below.

# FOR FURTHER INFORMATION CONTACT:

For more information regarding this meeting, contact Designated Federal Official Connie Athman; Mt. Hood National Forest; 16400 Champion Way; Sandy, Oregon 97055; (503) 668-1672.

Dated: September 28, 2009.

Kathryn J. Silverman,

Deputy Forest Supervisor.

[FR Doc. E9-23789 Filed 10-5-09; 8:45 am]

BILLING CODE 3410-11-M
<TABLE> <S> <C>

<ARTICLE>            5
       
<S>                  <C>
<PERIOD-TYPE>        6-MOS
<FISCAL-YEAR-END>    DEC-31-1997
<PERIOD-END>         JUN-30-1997
<CASH>               847,603
<SECURITIES>                          0    
<RECEIVABLES>                         180,496   
<ALLOWANCES>                          0
<INVENTORY>                           0
<CURRENT-ASSETS>     0
<PP&E>               13,426,008    <F1>
<DEPRECIATION>                        3,261,825
<TOTAL-ASSETS>                        11,858,611
<CURRENT-LIABILITIES>                 253,136
<BONDS>                               8,877,825    <F2>
<PREFERRED-MANDATORY>                 0
<PREFERRED>                           0
<COMMON>                              2,727,650    <F3>
<OTHER-SE>                            0
<TOTAL-LIABILITY-AND-EQUITY> 11,858,611
<SALES>                               0
<TOTAL-REVENUES>     1,217,195    <F4>
<CGS>                0
<TOTAL-COSTS>                         1,048,229    <F5>
<OTHER-EXPENSES>     0         
<LOSS-PROVISION>     0
<INTEREST-EXPENSE>                    0
<INCOME-PRETAX>                       0
<INCOME-TAX>                          0
<INCOME-CONTINUING>                   0
<DISCONTINUED>                        0
<EXTRAORDINARY>                       0
<CHANGES>                             0
<NET-INCOME>                          168,966
<EPS-PRIMARY>                         0
<EPS-DILUTED>                         0

<FN>
<F1>   "PP&E" REPRESENTS INVESTMENT IN REAL ESTATE [LAND AND
BUILDING]


<F2>   "BONDS" REPRESENTS MORTGAGES PAYABLE
<F3>   "COMMON" REPRESENTS TOTAL PARTNERS CAPITAL
<F4>   "TOTAL REVENUES" REPRESENTS RENTAL, INTEREST, AND OTHER
INCOME
<F5>   "TOTAL COSTS" REPRESENTS TOTAL EXPENSES LESS INTEREST
EXPENSE 
</FN>
        

</TABLE>